237 related articles for article (PubMed ID: 16889960)
81. Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
Osman NA; Ligresti A; Klein CD; Allarà M; Rabbito A; Di Marzo V; Abouzid KA; Abadi AH
Eur J Med Chem; 2016 Oct; 122():619-634. PubMed ID: 27448919
[TBL] [Abstract][Full Text] [Related]
82. Benzofuran and pyrrole derivatives as cannabinoid receptor modulators with
Wadea NE; Issac MM; Osman NA; Abadi AH
Future Med Chem; 2019 Dec; 11(24):3139-3159. PubMed ID: 31838898
[No Abstract] [Full Text] [Related]
83. Allosterism and cannabinoid CB(1) receptors: the shape of things to come.
Ross RA
Trends Pharmacol Sci; 2007 Nov; 28(11):567-72. PubMed ID: 18029031
[TBL] [Abstract][Full Text] [Related]
84. Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Yamaguchi T; Tomishima Y; Futaki N; Toda Y; Saito S
Bioorg Med Chem; 2008 Feb; 16(3):1111-24. PubMed ID: 18006322
[TBL] [Abstract][Full Text] [Related]
85. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
[TBL] [Abstract][Full Text] [Related]
86. Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents.
Wiley JL; Smith VJ; Chen J; Martin BR; Huffman JW
Bioorg Med Chem; 2012 Mar; 20(6):2067-81. PubMed ID: 22341572
[TBL] [Abstract][Full Text] [Related]
87. 2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.
Gleave RJ; Beswick PJ; Brown AJ; Giblin GM; Haslam CP; Livermore D; Moses A; Nicholson NH; Page LW; Slingsby B; Swarbrick ME
Bioorg Med Chem Lett; 2009 Dec; 19(23):6578-81. PubMed ID: 19864133
[TBL] [Abstract][Full Text] [Related]
88. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Börner C; Höllt V; Sebald W; Kraus J
J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
[TBL] [Abstract][Full Text] [Related]
89. Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists.
Kim JY; Seo HJ; Lee SH; Jung ME; Ahn K; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Jan; 19(1):142-5. PubMed ID: 19022666
[TBL] [Abstract][Full Text] [Related]
90. Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists.
Lange JH; Attali A; van der Neut MA; Wals HC; Mulder A; Zilaout H; Duursma A; van Aken HH; van Vliet BJ
Bioorg Med Chem Lett; 2010 Sep; 20(17):4992-8. PubMed ID: 20688519
[TBL] [Abstract][Full Text] [Related]
91. Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists.
Raitio KH; Savinainen JR; Vepsäläinen J; Laitinen JT; Poso A; Järvinen T; Nevalainen T
J Med Chem; 2006 Mar; 49(6):2022-7. PubMed ID: 16539390
[TBL] [Abstract][Full Text] [Related]
92. Synthesis of quinolinyl and isoquinolinyl phenyl ketones as novel agonists for the cannabinoid CB2 receptor.
Reux B; Nevalainen T; Raitio KH; Koskinen AM
Bioorg Med Chem; 2009 Jul; 17(13):4441-7. PubMed ID: 19477133
[TBL] [Abstract][Full Text] [Related]
93. Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors.
Durdagi S; Reis H; Papadopoulos MG; Mavromoustakos T
Bioorg Med Chem; 2008 Aug; 16(15):7377-87. PubMed ID: 18595717
[TBL] [Abstract][Full Text] [Related]
94. CB2 receptor ligands.
Huffman JW
Mini Rev Med Chem; 2005 Jul; 5(7):641-9. PubMed ID: 16026310
[TBL] [Abstract][Full Text] [Related]
95. Controlled-deactivation cannabinergic ligands.
Sharma R; Nikas SP; Paronis CA; Wood JT; Halikhedkar A; Guo JJ; Thakur GA; Kulkarni S; Benchama O; Raghav JG; Gifford RS; Järbe TU; Bergman J; Makriyannis A
J Med Chem; 2013 Dec; 56(24):10142-57. PubMed ID: 24286207
[TBL] [Abstract][Full Text] [Related]
96. Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligand.
Chianese G; Fattorusso E; Taglialatela-Scafati O; Bavestrello G; Calcinai B; Dien HA; Ligresti A; Di Marzo V
Steroids; 2011; 76(10-11):998-1002. PubMed ID: 21530566
[TBL] [Abstract][Full Text] [Related]
97. Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists.
Chu CM; Hung MS; Hsieh MT; Kuo CW; Suja TD; Song JS; Chiu HH; Chao YS; Shia KS
Org Biomol Chem; 2008 Sep; 6(18):3399-407. PubMed ID: 18802648
[TBL] [Abstract][Full Text] [Related]
98. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor.
Marriott KS; Huffman JW
Curr Top Med Chem; 2008; 8(3):187-204. PubMed ID: 18289088
[TBL] [Abstract][Full Text] [Related]
99. Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands.
Bhattacharjee H; Gurley SN; Moore BM
Bioorg Med Chem Lett; 2009 Mar; 19(6):1691-3. PubMed ID: 19230659
[TBL] [Abstract][Full Text] [Related]
100. Synthesis and investigations on the oxidative degradation of C3/C5-alkyl-1,2,4-triarylpyrroles as ligands for the estrogen receptor.
Schäfer A; Wellner A; Gust R
ChemMedChem; 2011 May; 6(5):794-803. PubMed ID: 21416612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
